Observed Signal · Oct 26, 2026 · Funding · Source: Tech.eu (European Tech & Deals) · Impact: 2/5 · Sentiment: Positive
Venture Kick invests CHF 150K in CHD for pregnancy monitoring
Swiss medtech startup CHD (Connected Health Development) has received approximately €160,000 (CHF 150,000) from Venture Kick to develop its digital solutions for remote maternal and fetal monitoring. The funding will support the development, testing, and validation of CHD's MONI2 solution, a smart textile belt that collects maternal and fetal ECG data, uterine contractions, fetal movements, and fetal position. CHD aims to improve access to maternal healthcare, enable earlier detection of complications, and reduce hospital visits for high-risk pregnancies. The company plans to launch consumer and medical versions of MONI2, targeting sales of over 30,000 kits and subscriptions within four years. CEO Laurent Vandebrouck stated that the Venture Kick support is part of CHD's initial seed fundraising, with other investors and a foundation committing or considering funding, aiming to close the round by October.
The news is about a healthtech startup receiving seed funding, which is relevant to the broader tech ecosystem but not directly related to AdTech, MarTech, or digital advertising. However, it may interest investors in the tech sector.
Track Venture Kick Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- CHD receives CHF 150,000 (approx. €160,000) from Venture Kick.
- CHD develops MONI2, a smart textile belt for remote maternal and fetal monitoring.
- MONI2 collects maternal and fetal ECG, uterine contractions, fetal movements, and position.
- CHD targets sales of over 30,000 kits and subscriptions within four years.
- The funding is part of CHD's initial seed round, aiming to close by October.
Connected Companies & Entities
1 Entity mapped“Venture Kick supports Swiss start-ups and has backed CHD with CHF 150,000.”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Venture Kick invests CHF 150K in Apolarion's plasma seed treatment
Swiss cleantech startup Apolarion, a spin-off from EPFL, has received CHF 150,000 (€164,000) from Venture Kick to advance its chemical-free seed treatment technology. The company, founded by Jesus Poley and Luke Simons, is developing a modular device that uses cold atmospheric plasma to eliminate harmful microorganisms from seeds without chemical treatments. This method uses only air and electricity to generate reactive particles that neutralize pathogens while preserving seed germination. The funding will support first field trials and initial customer deployments, covering operational facilities, equipment, and personnel. Apolarion initially targets Swiss and European markets, offering sustainable alternatives to conventional chemical and heat-based treatments for seed treatment companies.
DHDL: Ralf Dümmel invests in Zenny
Zenny, a startup founded by Jelena Meyer Vicente, offers acupressure patches for the ear as a self-care product. On the German TV show "Die Höhle der Löwen" (Shark Tank), she pitched for a €100,000 investment in exchange for 10% equity. Despite initial skepticism from other investors about market size, Ralf Dümmel struck a deal, investing €100,000 for 20% of the company after negotiations. The deal was finalized after due diligence. Following the show, Zenny is set to be available in all Rossmann stores nationwide starting January 2027, with additional retail placements at Kaufland, Lidl, and Netto. The startup plans to expand into the sports sector and pharmacies.
Aeon Acquires Aware Health, Expands Seed Funding
Zurich-based HealthTech startup Aeon has closed a seed extension, bringing total seed funding to over $14 million (€12 million), and acquired core assets of German blood diagnostics platform Aware Health. The round was co-led by Araya Ventures with participation from existing investors including Concentric, GoHub Ventures, Kadmos Capital, N&V Capital, Bigwave Capital, and Calm/Storm Ventures. The acquisition includes Aware Health's technology platform, contracts, laboratory integrations, network of 45+ blood-draw locations, and customer base of nearly 10,000 active users, with data handled under GDPR. Aeon integrates whole-body MRI with recurring blood diagnostics and AI to create a continuous, longitudinal health record for predictive analytics. The company appointed Pablo Tano as AI lead, marking its second acquisition following Holsain, and accelerates European expansion. Financial details were not disclosed.
Receive all future signals for Venture Kick & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.